[Prevention of restenosis after PTCA and patient's QOL].
Okamoto
Shinya
S
Department of Internal Medicine, Nabari City Hospital.
Ishisu
Ryoichi
R
Yamakado
Tetsu
T
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000627:therapeutic use; D017225:Atherectomy, Coronary; D023903:Coronary Restenosis / Q000517:prevention & control*; D005395:Fish Oils / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011341:Probucol / Q000627:therapeutic use; D011788:Quality of Life; D015607:Stents
D000959:Antihypertensive Agents; D005395:Fish Oils; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D010975:Platelet Aggregation Inhibitors; D011341:Probucol